Cargando…

PD-1H Expression Associated With CD68 Macrophage Marker Confers an Immune-Activated Microenvironment and Favorable Overall Survival in Human Esophageal Squamous Cell Carcinoma

Esophageal squamous cell carcinoma (ESCC) is the most common type of esophageal carcinoma (EC) in China. Although the PD-1 inhibitor pembrolizumab has been approved to treat patients with EC, its therapeutic efficacy is limited. Thus, additional immunotherapeutic targets for EC treatment are needed....

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Yuangui, Feng, Rui, He, Bailin, Wang, Jun, Xian, Na, Huang, Gangxiong, Zhang, Qiuyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Molecular Biosciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688962/ https://www.ncbi.nlm.nih.gov/pubmed/34950702 http://dx.doi.org/10.3389/fmolb.2021.777370

Ejemplares similares

A Novel Ferroptosis-Related Biomarker Signature to Predict Overall Survival of Esophageal Squamous Cell Carcinoma
por: Song, Jiahang, et al.
Publicado: (2021)

Identification of the Prognostic Value of Tumor Microenvironment-Related Genes in Esophageal Squamous Cell Carcinoma
por: Zhang, Donglei, et al.
Publicado: (2020)

Deciphering Treg cell roles in esophageal squamous cell carcinoma: a comprehensive prognostic and immunotherapeutic analysis
por: Zhang, Pengpeng, et al.
Publicado: (2023)

Aberrations in ion channels interacting with lipid metabolism and epithelial–mesenchymal transition in esophageal squamous cell carcinoma
por: Parthasarathi, K. T. Shreya, et al.
Publicado: (2023)

Ferroptosis-Related Gene Signature and Patterns of Immune Infiltration Predict the Overall Survival in Patients With Lung Adenocarcinoma
por: Wang, Yuxuan, et al.
Publicado: (2021)

Metabolomic Characterization Reveals ILF2 and ILF3 Affected Metabolic Adaptions in Esophageal Squamous Cell Carcinoma
por: Zang, Bin, et al.
Publicado: (2021)

Integrative Genomic Analyses of 1,145 Patient Samples Reveal New Biomarkers in Esophageal Squamous Cell Carcinoma
por: Zou, Binbin, et al.
Publicado: (2022)

CCR7 Has Potential to Be a Prognosis Marker for Cervical Squamous Cell Carcinoma and an Index for Tumor Microenvironment Change
por: Tian, Wei-Jie, et al.
Publicado: (2021)

An Extracellular Matrix-Based Signature Associated With Immune Microenvironment Predicts the Prognosis and Therapeutic Responses of Patients With Oesophageal Squamous Cell Carcinoma
por: Zhang, Hongpan, et al.
Publicado: (2021)

Aberrant Methylation and Immune Microenvironment Are Associated With Overexpressed Fibronectin 1: A Diagnostic and Prognostic Target in Head and Neck Squamous Cell Carcinoma
por: Sheng, Surui, et al.
Publicado: (2021)

Circulating neutrophils activated by cancer cells and M2 macrophages promote gastric cancer progression during PD-1 antibody-based immunotherapy
por: Zhou, Chenfei, et al.
Publicado: (2023)

Substitution of Arginine 120 in Human D-Amino Acid Oxidase Favors FAD-Binding and Nuclear Mistargeting
por: Murtas, Giulia, et al.
Publicado: (2019)

Construction of a Two-Gene Immunogenomic-Related Prognostic Signature in Lung Squamous Cell Carcinoma
por: Zhang, Xiaoting, et al.
Publicado: (2022)

Editorial: Tumor microenvironment in cancer hallmarks and therapeutics
por: Luo, Na
Publicado: (2022)

The progress of microenvironment-targeted therapies in brain metastases
por: Long, Lifu, et al.
Publicado: (2023)

Development and Validation of Ten-RNA Binding Protein Signature Predicts Overall Survival in Osteosarcoma
por: Zhang, Jian, et al.
Publicado: (2021)

Immune-Related lncRNA Signature for Predicting the Immune Landscape of Head and Neck Squamous Cell Carcinoma
por: Yin, Ji, et al.
Publicado: (2021)

Tumor Microenvironment-Stimuli Responsive Nanoparticles for Anticancer Therapy
por: Thomas, Reju George, et al.
Publicado: (2020)

CD74 Correlated With Malignancies and Immune Microenvironment in Gliomas
por: Xu, Shengchao, et al.
Publicado: (2021)

Unveiling Tumor Microenvironment Interactions Using Zebrafish Models
por: Loveless, Reid, et al.
Publicado: (2021)

Combination of Radiosensitivity Gene Signature and PD-L1 Status Predicts Clinical Outcome of Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma: A Study Based on The Cancer Genome Atlas Dataset
por: Dai, Dongjun, et al.
Publicado: (2021)

Investigating the Role of the N-Terminal Loop of PD-1 in Binding Process Between PD-1 and Nivolumab via Molecular Dynamics Simulation
por: Liu, Wenping, et al.
Publicado: (2020)

Ferroptosis and its emerging role in esophageal cancer
por: Maimaitizunong, Rezeye, et al.
Publicado: (2022)

Decreased CDKL2 Expression in Clear Cell Renal Cell Carcinoma Predicts Worse Overall Survival
por: Chen, Zhan, et al.
Publicado: (2022)

Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy
por: Henke, Erik, et al.
Publicado: (2020)

Corrigendum: Tumor Microenvironment-Stimuli Responsive Nanoparticles for Anticancer Therapy
por: Thomas, Reju George, et al.
Publicado: (2021)

Editorial: Molecular targeting of the tumor microenvironment for therapeutics in cancer metastasis
por: Dasari, Subramanyam, et al.
Publicado: (2023)

Editorial: Volume II: Tumor microenvironment in cancer hallmarks and therapeutics
por: Shi, Rongchen, et al.
Publicado: (2023)

SERS Based Lateral Flow Assay for Rapid and Ultrasensitive Quantification of Dual Laryngeal Squamous Cell Carcinoma-Related miRNA Biomarkers in Human Serum Using Pd-Au Core-Shell Nanorods and Catalytic Hairpin Assembly
por: Li, Guang, et al.
Publicado: (2022)

Construction and External Validation of a Ferroptosis-Related Gene Signature of Predictive Value for the Overall Survival in Bladder Cancer
por: Liu, Jingchao, et al.
Publicado: (2021)

Role of a Modified Urothelium Immune Prognostic Index in Patients With Metastatic Urothelial Carcinoma Treated With Anti–PD-1/PD-L1–Based Therapy
por: Li, Haifeng, et al.
Publicado: (2021)

Editorial: The “proteine 2022” conference
por: Balestri, Francesco, et al.
Publicado: (2023)

Tumor-Derived Extracellular Vesicles Regulate Cancer Progression in the Tumor Microenvironment
por: Bao, Qianqian, et al.
Publicado: (2022)

Role of LGMN in tumor development and its progression and connection with the tumor microenvironment
por: Khan, Safir Ullah, et al.
Publicado: (2023)

Tumor microenvironment and epithelial-mesenchymal transition in bladder cancer: Cytokines in the game?
por: Martins-Lima, Cláudia, et al.
Publicado: (2023)

The signature of pyroptosis-related gene prognostic and immune microenvironment in adrenocortical carcinoma
por: Gao, Jun, et al.
Publicado: (2023)

Macrophage Plasticity and Atherosclerosis Therapy
por: Lin, Ping, et al.
Publicado: (2021)

Development and External Validation of a Novel Immune Checkpoint–Related Gene Signature for Prediction of Overall Survival in Hepatocellular Carcinoma
por: Zhao, Enfa, et al.
Publicado: (2021)

A ferroptosis-related gene signature and immune infiltration patterns predict the overall survival in acute myeloid leukemia patients
por: Yin, Zhao, et al.
Publicado: (2022)

Gastrointestinal Microenvironment and the Gut-Lung Axis in the Immune Responses of Severe COVID-19
por: Yang, Yun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1rs5n8r6aooqfkmogj7u1qfhv4